Quanta Inc. in Burbank has agreed to acquire a 51 percent stake in Medolife Rx, a Wyoming company that uses patented polarization technology to make anti-viral and immune-boosting therapeutics.
Medolife will receive newly created preferred stock from Quanta, giving its shareholders majority voting control of the combined entity upon closing. The transaction is a reverse merger where the acquired business goes public without having to file paperwork for an initial public offering.
Quanta is listed on the over-the-counter markets. Shares are currently trading at around 5 cents – down from about 48 cents a share at the beginning of 2020. The company was a developer of CBD products prior to the transaction with Medolife.